Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
He was talking about Tiziana share price when he said that though, and any sale would not involve Tiziana
....he said there was a catalyst coming in a couple of weeks, that could be it!
Utter total shambles & please don't tell me they don't care about shareholders. Without us how they meant to progress..
Some of you's coming on here " i bought this much I bought that much on the Dip" WE DONT CARE! stop talking out of your backside, cause we all know you are just trying to justify how balls deep in RED you are.
We just want our Accustem shares & most will leave when they break even. They must know what the sentiments are of the shareholders, cause i know they can read! Businessmen that they are not..
The only thing they mentioned was an issue with ADR and then stated they could not discuss further...
Hopefully someone with more knowledge of this can advise, but I don't see why they couldn't give more in depth information about what the issue actually is, surely they are not bound by secrecy over issues with ADR, surely they could have put some more meat on the bone?
The way they skirted around the question got me thinking that they could be in talks to sell. I know i'm probably getting ahead of myself, but it was fairly obvious that she did not want to give too much away. If it was only ADR issue, I don't see why she would be so evasive. Thoughts ?
Why is the Accustem listing taking so long? Currently they have taken/removed a valuable asset from Tiziana Shareholders by way of a capital reduction approved by the court, but have not compensated Shareholders for their loss, by issuing them Accustem shares. I'll have to read the documents but I cannot envisage the court giving a Company an open ended timeline on closure as it would allow Companies to hive off assets at will.
Happyish....I think they have taken the **** with accustem....the pain that the accustem saga has caused has been undeniable and continues to be a sore point the longer that it goes on.
Thanks to FFF, GTFC, Hundal
really appreciated
Greens- No he didn't elaborate on it, it was almost an off the cuff remark. He was talking about MS and Crohns phase 2 and then said something like " we could see a catalyst in a few weeks"
My takeaways from the call:
It was good to hear Kunwar run though the top line data results for the Brazil Phase 1 trial. These show that there is merit in moving to a further trial with a greater number of patients, including those with severe disease. This could lead to Government / Pharma interest. News on when this can be started will to be announced shortly.
Whilst these trials are important, it seems the real drivers (‘Key Milestones’, as Kunwar referred to them) are Crohns and MS. They are much further along with these and there appears to be real interest from Pharma’s. End 2021 should be very interesting.
They didn’t want the call to be side-tracked by Accustem questions. They’ll update us when they can (or want to).
All sounds positive. Lot of activity in H1, with Crohns and MS trials, and the broadened Covid ph2. Assume we'll get top line data in the next couple of weeks which takes us to mid March, and then the trials above kicking off Apr-Jun....
Intrigued by the "major catalyst in next few weeks" FFF...did they elaborate further?
Thanks!
Thanks FFF.
Keeren Shah, Finance Dir at TILS
Thanks Rockz
Just got of the call.
Everything positive, my only concern is that the time frames may not please everyone. Certainly a lot more positive for long term biotech holders than short term traders, hopefully our shareholders base has now already flushed out the latter. Gla
Stims, her name was Keiran Shah, finance officer, she seemed on the ball, quick but to the point with her answers.
She confirmed that Accustem is currently going through the regulatory process of delivering shares to ADR shareholders. She wouldn’t commit to a timescale on this.
Once recording available, I think it would be good to do a full write up of the Q&A to stick up on here...
You're welcome, apologies again for the spellings, hopefully it all makes sense.
Thanks FFF
Nice one FFF, much appreciated
Thank you fullfathomfive!
Start wasn't great, but really pleased with some if the responses to the questions...
I feel a lot better after that !
Thank you for all the information. Brilliant.
End of 2021 is going to be great, the end !!!!!
Q. Why should we invest in Tiziana
A. Look at the team, we have experience of concept to market drugs. If one of our drugs goes to market, its a game changer (my words, nit the goid Drs)
Q. Why share price dropping
A. I understand concerns and I'm frustrated, everything on track, no bad news, stock market beyond his control. I assure you no negative news
Chosen MS route due to interest from big pharma.....
Will be watching the recording again....